|
|
|
Insider
Information: |
Mahony Susan |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
40,685 |
|
Indirect Shares
|
18,339 |
|
|
Direct
Value |
$36,984,292 |
|
|
Indirect Value
|
$16,670,885 |
|
|
Total
Shares |
59,024 |
|
|
Total
Value |
$53,655,177 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Eli Lilly & Co |
LLY |
SVP & Pres., Lilly Onc... |
2018-04-16 |
40,685 |
2018-04-16 |
18,339 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HZNP |
Horizon Pharma, Inc. |
Director |
|
2023-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,913 |
3,913 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP, Human Resources |
|
2013-11-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,056 |
47,936 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2022-04-29 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,223 |
18,275 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2021-04-30 |
4 |
D |
$94.62 |
$412,259 |
I/I |
(4,357) |
14,052 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2017-02-01 |
4 |
D |
$77.03 |
$352,027 |
D/D |
(4,570) |
91,470 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2016-12-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,584 |
14,117 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2016-02-01 |
4 |
D |
$79.10 |
$366,154 |
D/D |
(4,629) |
86,895 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2020-05-02 |
4 |
D |
$35.62 |
$168,305 |
I/I |
(4,725) |
7,311 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2013-02-01 |
4 |
AS |
$54.28 |
$271,400 |
D/D |
(5,000) |
52,380 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2013-03-26 |
4 |
AS |
$56.00 |
$280,000 |
D/D |
(5,000) |
47,380 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2018-04-13 |
4 |
AS |
$80.14 |
$413,923 |
D/D |
(5,165) |
45,652 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2015-02-01 |
4 |
D |
$72.00 |
$426,312 |
D/D |
(5,921) |
87,487 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2014-02-01 |
4 |
D |
$54.01 |
$357,924 |
D/D |
(6,627) |
82,798 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2014-08-13 |
4 |
D |
$60.88 |
$474,194 |
D/D |
(7,789) |
53,530 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2015-02-11 |
4 |
D |
$70.50 |
$568,583 |
D/D |
(8,065) |
87,728 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2014-08-13 |
4 |
OE |
$55.65 |
$474,194 |
D/D |
8,521 |
61,319 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP, Human Resources |
|
2010-01-26 |
4 |
A |
$36.16 |
$315,026 |
D/D |
8,712 |
18,246 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2015-02-11 |
4 |
OE |
$56.18 |
$507,642 |
D/D |
9,036 |
95,793 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP, HR & Diversity |
|
2011-01-25 |
4 |
A |
$34.73 |
$322,885 |
D/D |
9,297 |
27,543 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2023-10-06 |
4 |
D |
$116.50 |
$1,084,149 |
I/I |
(9,306) |
0 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2023-10-06 |
4 |
D |
$116.50 |
$1,088,693 |
D/D |
(9,345) |
0 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2018-02-01 |
4 |
D |
$81.45 |
$776,463 |
D/D |
(9,533) |
50,817 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,732 |
96,040 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,843 |
91,524 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & Pres., Lilly Oncology |
|
2012-10-24 |
4 |
S |
$50.45 |
$504,500 |
D/D |
(10,000) |
20,620 |
0 |
- |
|
70 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|